| CD24FC | Unknown | metastatic melanoma | Heat shock protein HSP90 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| RETASPIMYCIN | Small molecule | breast carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | malignant peripheral nerve sheath tumor | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | gastrointestinal stromal tumor | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | adult T-cell leukemia/lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| CD24FC | Unknown | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| LUMINESPIB | Small molecule | malignant colon neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | gastroesophageal junction adenocarcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | gastric cancer | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | gastric cancer | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| BIIB021 | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| ONALESPIB | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN | Small molecule | metastatic melanoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| LUMINESPIB | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | cutaneous melanoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | lymphoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | anaplastic large cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | gastric cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVESPIMYCIN | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | follicular lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Burkitts lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| BIIB021 | Small molecule | lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | adult T-cell leukemia/lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | fallopian tube cancer | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| SNX 5422 | Small molecule | lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN | Small molecule | dedifferentiated liposarcoma | Heat shock protein HSP90 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| RETASPIMYCIN | Small molecule | lung cancer | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| SNX 5422 | Small molecule | hematopoietic and lymphoid cell neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | lymphoblastic lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Lymphoma, AIDS-Related | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | angioimmunoblastic T-cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN | Small molecule | multiple myeloma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | cutaneous melanoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | mycosis fungoides | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Mantle cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | chondrosarcoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | chronic lymphocytic leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Waldenstrom macroglobulinemia | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ALVESPIMYCIN | Small molecule | chronic lymphocytic leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| SNX 5422 | Small molecule | cancer | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| LUMINESPIB | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | uterine sarcoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | gastrointestinal stromal tumor | Heat shock protein HSP90 inhibitor | 3.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | myelodysplastic syndrome | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | osteosarcoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN | Small molecule | prostate adenocarcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | rectum cancer | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | cancer | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | central nervous system non-hodgkin lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | metastatic melanoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| RETASPIMYCIN | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| LUMINESPIB | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | MALT lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | male breast carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Lymphoma, AIDS-Related | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | malignant colon neoplasm | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| BIIB021 | Small molecule | chronic lymphocytic leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | diffuse large B-cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | colorectal carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | ovarian cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | rectum cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | acute myeloid leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVESPIMYCIN | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| GANETESPIB | Small molecule | lung cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Splenic Marginal Zone Lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | angioimmunoblastic T-cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | chronic myeloproliferative disorder | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Mantle cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | lymphoblastic lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | prostate adenocarcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | lung cancer | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | multiple myeloma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | prostate adenocarcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| RETASPIMYCIN | Small molecule | cancer | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | pancreatic adenocarcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | malignant pleural mesothelioma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ONALESPIB | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| TANESPIMYCIN | Small molecule | diffuse large B-cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | MALT lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | cancer | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| BIIB021 | Small molecule | gastrointestinal stromal tumor | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | squamous cell lung carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| LUMINESPIB | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| GANETESPIB | Small molecule | pancreatic adenocarcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | prolymphocytic leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | leukemia | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | medullary thyroid gland carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | breast carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | melanoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | anaplastic large cell lymphoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | nodal marginal zone B-cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| BIIB021 | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| ALVESPIMYCIN | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | angiosarcoma | Heat shock protein HSP90 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| RETASPIMYCIN | Small molecule | gastrointestinal stromal tumor | Heat shock protein HSP90 inhibitor | 3.0 | Terminated | ClinicalTrials |
| RETASPIMYCIN | Small molecule | lung cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Ewing sarcoma/peripheral primitive neuroectodermal tumor | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | multiple myeloma | Heat shock protein HSP90 inhibitor | 3.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | mycosis fungoides | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | dedifferentiated liposarcoma | Heat shock protein HSP90 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| TANESPIMYCIN | Small molecule | lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | ovarian cancer | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | urinary bladder cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ONALESPIB | Small molecule | prostate cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ALVESPIMYCIN | Small molecule | prolymphocytic leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | prostate cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Sezary's disease | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| BIIB021 | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | esophageal carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ONALESPIB | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | head and neck malignant neoplasia | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | ovarian sarcoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | colorectal adenocarcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | rectum cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ONALESPIB | Small molecule | breast carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | anaplastic large cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | kidney cancer | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| RETASPIMYCIN | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Burkitts lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | lung adenocarcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | nodal marginal zone B-cell lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| SNX 5422 | Small molecule | leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | lung adenocarcinoma | Heat shock protein HSP90 inhibitor | 3.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | lymphoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Hodgkins lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Hodgkins lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Hodgkins lymphoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | primary peritoneal carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| ONALESPIB | Small molecule | neoplasm | Heat shock protein HSP90 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SNX 5422 | Small molecule | cancer | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | hepatocellular carcinoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Mantle cell lymphoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | papillary thyroid carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | Sezary's disease | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | multiple myeloma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| CD24FC | Unknown | COVID-19 | Heat shock protein HSP90 inhibitor | 3.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | melanoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| GANETESPIB | Small molecule | melanoma | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| TANESPIMYCIN | Small molecule | kidney cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | multiple myeloma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | chronic lymphocytic leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Terminated | ClinicalTrials |
| LUMINESPIB | Small molecule | gastrointestinal stromal tumor | Heat shock protein HSP90 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| TANESPIMYCIN | Small molecule | follicular lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | gastric cancer | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | small intestine lymphoma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | lung cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | prostate adenocarcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | gastrointestinal stromal tumor | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | lung cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUMINESPIB | Small molecule | myeloproliferative disorder | Heat shock protein HSP90 inhibitor | 2.0 | Terminated | ClinicalTrials |
| RETASPIMYCIN HYDROCHLORIDE | Small molecule | multiple myeloma | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| TANESPIMYCIN | Small molecule | leukemia | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| GANETESPIB | Small molecule | triple-negative breast cancer | Heat shock protein HSP90 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SNX 5422 | Small molecule | cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| ONALESPIB | Small molecule | breast cancer | Heat shock protein HSP90 inhibitor | 1.0 | Completed | ClinicalTrials |
| RETASPIMYCIN | Small molecule | non-small cell lung carcinoma | Heat shock protein HSP90 inhibitor | 2.0 | Completed | ClinicalTrials |